Abstract
Pharmacology, Toxicology and Biomedical Reports,2019,5,1,44-48.DOI:10.5530/PTB.2019.5.8Published:January 2019Type:Research ArticleAuthors:Yousef Ahmed Alomi, Nesreen Alshabaar, Nadia Lubad, and Fatimah Ali Albusalih Author(s) affiliations:Yousef Ahmed Alomi*, The Past General Manager of General Administration of Pharmaceutical Care Head, National Clinical Pharmacy and Pharmacy Practice Head, Pharmacy R & D Administration, Ministry of Health, Riyadh 11392, SAUDI ARABIA. Nesreen Alshabaar, King Salman Hospital, Ministry of Health, Riyadh 11392, SAUDI ARABIA. Nadia Lubad, King Salman Hospital, Ministry of Health, Riyadh 11392, Riyadh, SAUDI ARABIA. Fatimah Ali Albusalih, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University (University of Dammam) Dammam, SAUDI ARABIA. Abstract:Objectives: To explore the inpatient medication errors and pharmacist intervention at Ministry of Health Hospital, Riyadh, Saudi Arabia. Methods: This is a 9-month cross-sectional study conducted at a 300-bed public hospital to evaluate pharmacist response and prevention of inpatient medication errors in adult and pediatric patients. There is a medication safety officer in the hospital along with a medication safety committee. The following information on medication errors were documented in the form available at the hospital: patient’s demographic information, sources of medication errors, time of errors, type of errors, description of errors, causes of errors, recommendation to prevent such errors and the outcome of errors. The form was developed by using the National Coordinating Council (NCC) for Medication Error Reporting and Prevention (MERP) system. Results: According to the results, the pharmacist prevented a total of 3089 medication errors within 805 patients. About 3.8 errors per prescription were prevented. Most of the prevention occurred during prescribing stage (705 (99.2%)). Patient-related errors (1564 (50.63%)) and prescriber-related errors (1435 (46.46%)) were the most type of prevented errors. Allergy was the most prevented subtype of errors (560 (91.4%)) followed by patient’s body weight (543 (88.6%)) and prescriber data missing/unclear (347 (56.6%)). Most of the errors that were prevented were near miss (93.3%) followed by 6.3% of the errors that reached the patient but did not cause any harm. The highest percentage with respect to the causes of medication errors was missing clinical information (649 (83.7%)) and miscommunication of drug order (627 (80.9%)). The top 20 medications involved in medication errors were oral and intravenous injections (Paracetamol and enoxaparin injection, respectively). Conclusion: The pharmacist plays a very crucial role in preventing medication errors. In order to prevent medication errors and improve patient outcome, the pharmacist provides education to the healthcare professional about medication safety and establishes the intravenous medication guidelines. Keywords:Inpatient, Intervention, Medication errors, Ministry of Health, Pharmacist, Riyadh, Saudi ArabiaView:PDF (192.53 KB) PDF PDF Images Table 2A: Pharmacist intervention of stage of medication operation.
Highlights
Clinical pharmacist plays a vital role in patient’s care at hospitals
Et al.: Inpatient Medication Errors and Pharmacist Intervention in Saudi Arabia we aimed to explore the inpatient Medication errors (MEs) and pharmacist’s intervention at Ministry of Health (MOH) public hospital, Riyadh, Saudi Arabia
In 2014, the Department of Pharmacy established Medication Safety Program. This program was founded in 2013 in Riyadh Region. It was a part of National Medication Safety Program of MOH and the Central Committee of Medication Committee is headed by the first author of this article
Summary
Researchers are placing more emphasis on the relationship between the pharmacist and the patient.[1] Training and experience of clinical pharmacists is considered unique because it is focused on therapeutics, as well as patient and provider providence of comprehensive drug management and by providers, we mean different healthcare professionals.[1] Quality of life, economics, satisfaction of patient, appropriateness of medications, adverse reactions and events are the primary outcomes of the pharmacist intervention.[1] MEs can be defined as incidents that occur in the medication processing regardless of the stage of origin and whether they cause harm to the patient.[2] To be more specific, an ME is an occasion that can be prevented and may cause or prompt improper drug usage or harm patient regardless of the time of occurrence or when the drug was under the supervision of patient, consumer or healthcare professional Such occasions might be identified with proficient practice, medicinal service items, techniques and frameworks, including compounding product labeling, dispensing, prescribing, monitoring order communication, administration, packaging, nomenclature, distribution and use.[3] It is noteworthy that MEs should not be mistaken for adverse drug reactions.[4] An adverse drug reaction is defined as “an impact that is poisonous and unintended which happens at measurements utilized for prophylaxis, determination or therapy”.5. In this study, PTB Reports, Vol 5, Issue 1, Jan-Apr, 2019
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
